+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Working with govt, key stakeholders to ensure continued supply of medicines: IPA

Mar 21, 2020, 18:06 IST
PTI
New Delhi, March 21 () The Indian Pharmaceutical Alliance (IPA) on Saturday said it along with its member companies is working with the government, various pharma industry associations in India and other key stakeholders in the pharmaceutical supply chain to ensure that patients in India and the world continue to have access to medicines.

The member companies are closely monitoring orders and inventories of medicines, it said.

Advertisement

"With an adequate stock of Active Pharmaceutical Ingredients (APIs), finished product formulations and channel availability, we would be able to sustain the supply of medicines for the coming months, the IPA said in a statement.

The pharma industry body also said that it is not aware of any medicines shortage, to date.

"We are working closely with the International Generic and Biosimilar Medicines Association (IGPA), World Health Organisation (WHO) headquarters in Switzerland and its India office, Association of Affordable Medicines (AAM) USA, Medicines for Europe and several other country associations to assess international developments and any potential impact on supply of medicines globally," the IPA said.

The IPA and its companies are aligned to government initiatives of containment measures and social distancing while meeting supply commitments in the essential services for availability of medicines, it added.

Advertisement

The IPA is committed to providing quality medicines to patients in India and across globe as patient centricity and welfare is fundamental to us, the statement said. AKT MKJ

(This story has not been edited by www.businessinsider.in and is auto–generated from a syndicated feed we subscribe to.)
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article